{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:25:54Z","timestamp":1757586354025},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T00:00:00Z","timestamp":1303862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s15010-011-0107-7","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T07:14:09Z","timestamp":1303802049000},"page":"239-245","source":"Crossref","is-referenced-by-count":13,"title":["Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy"],"prefix":"10.1007","volume":"39","author":[{"given":"T. J.","family":"Kowalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. L.","family":"Berth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Mathiason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"Agger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,27]]},"reference":[{"key":"107_CR1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089\u2013134.","journal-title":"Clin Infect Dis"},{"key":"107_CR2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","volume":"69","author":"JJ Halperin","year":"2007","unstructured":"Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69:91\u2013102.","journal-title":"Neurology"},{"key":"107_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s15010-010-0028-x","volume":"38","author":"S Bigi","year":"2010","unstructured":"Bigi S, Aebi C, Nauer C, et al. Acute transverse myelitis in Lyme neuroborreliosis. Infection. 2010;38:413\u20136.","journal-title":"Infection"},{"key":"107_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s15010-010-0062-8","volume":"39","author":"V Maraspin","year":"2011","unstructured":"Maraspin V, Ogrinc K, Ru\u017ei\u0107-Sablji\u0107 E, et al. Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans. Infection. 2011;39:35\u201340.","journal-title":"Infection"},{"key":"107_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","volume":"142","author":"GP Wormser","year":"2005","unstructured":"Wormser GP, McKenna D, Carlin J, et al. Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med. 2005;142:751\u20135.","journal-title":"Ann Intern Med"},{"key":"107_CR6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01971994","volume":"13","author":"H Kuiper","year":"1994","unstructured":"Kuiper H, de Jongh BM, van Dam AP, et al. Evaluation of central nervous system involvement in Lyme borreliosis patients with a solitary erythema migrans lesion. Eur J Clin Microbiol Infect Dis. 1994;13:379\u201387.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"107_CR7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jama.267.10.1364","volume":"267","author":"BJ Luft","year":"1992","unstructured":"Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992;267:1364\u20137.","journal-title":"JAMA"},{"key":"107_CR8","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archpedi.1997.02170490050009","volume":"151","author":"AL Belman","year":"1997","unstructured":"Belman AL, Reynolds L, Preston T, et al. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med. 1997;151:1224\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"107_CR9","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","volume":"357","author":"HM Feder Jr","year":"2007","unstructured":"Feder HM Jr, Johnson BJ, O\u2019Connell S, et al. A critical appraisal of \u201cchronic Lyme disease\u201d. N Engl J Med. 2007;357:1422\u201330.","journal-title":"N Engl J Med"},{"key":"107_CR10","first-page":"1358","volume":"102","author":"M Reimer","year":"2005","unstructured":"Reimer M. Peripheral facial paralysis? Exclude borreliosis, perform LP! Lakartidningen. 2005;102:1358.","journal-title":"Lakartidningen"},{"key":"107_CR11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1586\/14789072.2.1.S1","volume":"2","author":"D Cameron","year":"2004","unstructured":"Cameron D, Gaito A, Harris N, et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004;2:S1\u201313.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"107_CR12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ije\/dyi241","volume":"34","author":"ED Shapiro","year":"2005","unstructured":"Shapiro ED, Dattwyler R, Nadelman RB, et al. Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol. 2005;34:1437\u20139; author reply 1440\u20133.","journal-title":"Int J Epidemiol"},{"key":"107_CR13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/archpedi.1997.02170490009001","volume":"151","author":"ED Shapiro","year":"1997","unstructured":"Shapiro ED, Gerber MA. Lyme disease and facial nerve palsy. Arch Pediatr Adolesc Med. 1997;151:1183\u20134.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"107_CR14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","volume":"28","author":"L Dotevall","year":"1999","unstructured":"Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis. 1999;28:569\u201374.","journal-title":"Clin Infect Dis"},{"key":"107_CR15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","volume":"37","author":"R Borg","year":"2005","unstructured":"Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis. 2005;37:449\u201354.","journal-title":"Scand J Infect Dis"},{"key":"107_CR16","volume-title":"SF-36 health survey: manual and interpretation guide","author":"JE Ware","year":"1993","unstructured":"Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993."},{"key":"107_CR17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/649920","volume":"50","author":"TJ Kowalski","year":"2010","unstructured":"Kowalski TJ, Tata S, Berth W, et al. Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme disease-hyperendemic area. Clin Infect Dis. 2010;50:512\u201320.","journal-title":"Clin Infect Dis"},{"key":"107_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00005792-199103000-00001","volume":"70","author":"W Agger","year":"1991","unstructured":"Agger W, Case KL, Bryant GL, et al. Lyme disease: clinical features, classification, and epidemiology in the upper Midwest. Medicine (Baltimore). 1991;70:83\u201390.","journal-title":"Medicine (Baltimore)"},{"key":"107_CR19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/SMJ.0b013e31818860c0","volume":"101","author":"JL Hsu","year":"2008","unstructured":"Hsu JL, Banerjee D, Kuschner WG. Understanding and identifying bias and confounding in the medical literature. South Med J. 2008;101:1240\u20135.","journal-title":"South Med J"},{"key":"107_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","volume":"183","author":"RA Kalish","year":"2001","unstructured":"Kalish RA, Kaplan RF, Taylor E, et al. Evaluation of study patients with Lyme disease, 10\u201320-year follow-up. J Infect Dis. 2001;183:453\u201360.","journal-title":"J Infect Dis"},{"key":"107_CR21","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1542\/peds.112.2.e93","volume":"112","author":"M V\u00e1zquez","year":"2003","unstructured":"V\u00e1zquez M, Sparrow SS, Shapiro ED. Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics. 2003;112:e93\u20137.","journal-title":"Pediatrics"},{"key":"107_CR22","first-page":"257","volume":"18","author":"EE Smouha","year":"1997","unstructured":"Smouha EE, Coyle PK, Shukri S. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria. Am J Otol. 1997;18:257\u201361.","journal-title":"Am J Otol"},{"key":"107_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.49.3.817","volume":"49","author":"M Albisetti","year":"1997","unstructured":"Albisetti M, Schaer G, Good M, et al. Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology. 1997;49:817\u201324.","journal-title":"Neurology"},{"key":"107_CR24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/003655401300077225","volume":"33","author":"K Karkkonen","year":"2001","unstructured":"Karkkonen K, Stiernstedt SH, Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis. 2001;33:259\u201362.","journal-title":"Scand J Infect Dis"},{"key":"107_CR25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/00006454-200212000-00011","volume":"21","author":"C Thorstrand","year":"2002","unstructured":"Thorstrand C, Belfrage E, Bennet R, et al. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J. 2002;21:1142\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"107_CR26","unstructured":"Centers for Disease Control and Prevention (CDC) Division of Vector-Borne Infectious Diseases (DVBID). Reported cases of Lyme disease\u2013United States, 2009. CDC DVBID. 2010. http:\/\/www.cdc.gov\/ncidod\/dvbid\/Lyme\/ld_Incidence.htm . Accessed 5 Mar 2010."},{"key":"107_CR27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","volume":"33","author":"RA Kalish","year":"2001","unstructured":"Kalish RA, McHugh G, Granquist J, et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320\u00a0years after active Lyme disease. Clin Infect Dis. 2001;33:780\u20135.","journal-title":"Clin Infect Dis"},{"key":"107_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","volume":"123","author":"D Cerar","year":"2010","unstructured":"Cerar D, Cerar T, Ru\u017ei\u0107-Sablji\u0107 E, et al. Subjective symptoms after treatment of early Lyme disease. Am J Med. 2010;123:79\u201386.","journal-title":"Am J Med"},{"key":"107_CR29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","volume":"7","author":"U Lj\u00f8stad","year":"2008","unstructured":"Lj\u00f8stad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7:690\u20135.","journal-title":"Lancet Neurol"},{"key":"107_CR30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/INF.0b013e31816a1e29","volume":"27","author":"BH Skogman","year":"2008","unstructured":"Skogman BH, Croner S, Forsberg P, et al. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid. Pediatr Infect Dis J. 2008;27:605\u201312.","journal-title":"Pediatr Infect Dis J"},{"key":"107_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Lj\u00f8stad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010;17:8\u201316, e1\u2013e4.","journal-title":"Eur J Neurol"},{"key":"107_CR32","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/AAC.33.7.1078","volume":"33","author":"L Dotevall","year":"1989","unstructured":"Dotevall L, Hagberg L. Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob Agents Chemother. 1989;33:1078\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"107_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/AAC.28.2.347","volume":"28","author":"CW Yim","year":"1985","unstructured":"Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother. 1985;28:347\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"107_CR34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/313674","volume":"30","author":"L Dotevall","year":"2000","unstructured":"Dotevall L, Hagberg L. Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis. Clin Infect Dis. 2000;30:410\u20131.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-011-0107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-011-0107-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-011-0107-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T17:37:54Z","timestamp":1559497074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-011-0107-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,27]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1007\/s15010-011-0107-7","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,27]]}}}